NHT
GSK icon

New Hampshire Trust’s GSK GSK Stock Holding History

New Hampshire Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Hold
4,201
– – 0.04% 170
2026
Q1 		$232K Hold
4,201
– – 0.05% 148
2025
Q4 		$206K Buy
+4,201
New +$196K 0.04% 170
2023
Q2 		– Sell
-4,201
Closed -$149K – 235
2023
Q1 		$149K Buy
+4,201
New +$147K 0.04% 186

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

New Hampshire Trust's GSK Position: Q2 2026 in Review

New Hampshire Trust held its GSK (GSK) position steady in Q2 2026 at 4,201 shares worth $220K. The position accounts for 0.04% of the portfolio, ranked #170.

New Hampshire Trust first reported a position in GSK in Q1 2023 and has held it in 4 quarters since. The position peaked at $232K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • New Hampshire Trust held 4,201 shares of GSK worth $220K as of Q2 2026.
  • New Hampshire Trust left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.04% of New Hampshire Trust's portfolio in Q2 2026, its #170 holding.
  • New Hampshire Trust first reported a position in GSK in Q1 2023 and has held it in 4 quarters since.
  • New Hampshire Trust's GSK position peaked at $232K in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.